Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patients

[1]  A. Kallio,et al.  Individual FEV1 Trajectories Can Be Identified from a COPD Cohort , 2016, COPD.

[2]  S. Lambert,et al.  Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. , 2015, The New England journal of medicine.

[3]  S. Lawrence,et al.  Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. , 2015, The New England journal of medicine.

[4]  B. Celli,et al.  Lung-Function Trajectories and Chronic Obstructive Pulmonary Disease. , 2015, The New England journal of medicine.

[5]  Y. Oh,et al.  Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.

[6]  A. Ramírez-Venegas,et al.  FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. , 2014, American journal of respiratory and critical care medicine.

[7]  N. Metzdorf,et al.  Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial , 2014, BMC Pulmonary Medicine.

[8]  N. Chavannes,et al.  Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study , 2014, Primary care respiratory journal : journal of the General Practice Airways Group.

[9]  T. Dębowski,et al.  Chronic obstructive pulmonary disease in Poland: distribution of patients according to the new GOLD 2011 classification. Cross-sectional survey. , 2014, Pneumonologia i alergologia polska.

[10]  L. Edwards,et al.  Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort , 2013, European Respiratory Journal.

[11]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[12]  Morten Dahl,et al.  Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. , 2012, American journal of respiratory and critical care medicine.

[13]  J. Wedzicha,et al.  Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD , 2012, Thorax.

[14]  L. Edwards,et al.  Changes in forced expiratory volume in 1 second over time in COPD. , 2011, The New England journal of medicine.

[15]  G. Donaldson,et al.  Predictive accuracy of patient-reported exacerbation frequency in COPD , 2010, European Respiratory Journal.

[16]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[17]  S. Spencer,et al.  Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire. , 2007, Chest.

[18]  J. Hankinson,et al.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005, European Respiratory Journal.

[19]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[20]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[21]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[22]  M. Lebowitz,et al.  Epidemiology of chronic obstructive pulmonary disease. , 1990, Clinics in chest medicine.

[23]  C K Wells,et al.  Evaluation of clinical methods for rating dyspnea. , 1988, Chest.

[24]  L. Radloff.  The CES-D Scale , 1977 .

[25]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .